5.22

2.25% -0.12

Compass Pathways Plc Adr (CMPS)

Overview News Price History Option Chain Financials Discussions Forecast

Compass Pathways Plc Adr stock is traded at $5.22, with a volume of 2.17M. It is down -2.25% in the last 24 hours and down -34.67% over the past month. Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Previous Close:

$5.34

Open:

$5.3

24h Volume:

2.17M

Relative Volume:

0.81

Market Cap:

$592.56M

Revenue:

Net Income/Loss:

$-236.60M

P/E Ratio:

-1.9477

EPS:

-2.6801

Net Cash Flow:

$-161.34M

1W Performance:

-13.86%

1M Performance:

-34.67%

6M Performance:

-5.78%

1Y Performance:

+67.85%

1-Day Range:

$4.88

$5.31

1-Week Range:

$4.88

$6.115

52-Week Range:

$2.25

$8.90

Compass Pathways Plc Adr Stock (CMPS) Company Profile

Name

Compass Pathways Plc Adr

Sector

Healthcare (1113)

Industry

Medical Care Facilities (51)

Phone

1-716-676-6461

Address

3RD FLOOR, 1 ASHLEY ROAD, CHESIRE

Employee

166

Twitter

Next Earnings Date

2026-03-26

Latest SEC Filings

CMPS's Discussions on Twitter

Compare CMPS vs HCA, THC, FMS, ENSG, UHS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CMPS Compass Pathways Plc Adr	5.22	592.56M	0	-236.60M	-161.34M	-2.6801
HCA Hca Healthcare Inc	485.72	108.59B	75.60B	7.78B	7.69B	28.38
THC Tenet Healthcare Corp	199.63	17.36B	21.31B	2.37B	2.53B	15.49
FMS Fresenius Medical Care Ag Adr	22.03	12.31B	22.18B	1.36B	2.00B	1.9216
ENSG Ensign Group Inc	202.92	11.79B	5.06B	344.26M	370.71M	5.8446
UHS Universal Health Services Inc	185.92	11.36B	17.36B	1.51B	849.25M	23.15

Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-10-25	Upgrade	Oppenheimer	Perform → Outperform
Jun-23-25	Downgrade	Evercore ISI	Outperform → In-line
Feb-27-25	Initiated	Stifel	Buy
Jul-23-24	Initiated	RBC Capital Mkts	Outperform
Apr-01-24	Initiated	Morgan Stanley	Overweight
Dec-12-23	Initiated	Deutsche Bank	Buy
Nov-21-22	Resumed	Berenberg	Buy
Nov-01-22	Initiated	Loop Capital	Buy
Oct-29-21	Initiated	Oppenheimer	Outperform
Jul-13-21	Initiated	Citigroup	Buy
Jun-28-21	Initiated	Maxim Group	Buy
May-11-21	Initiated	Cantor Fitzgerald	Overweight
Apr-01-21	Initiated	ROTH Capital	Buy
Oct-14-20	Initiated	H.C. Wainwright	Buy
Oct-13-20	Initiated	Berenberg	Buy
Oct-13-20	Initiated	Canaccord Genuity	Buy
Oct-13-20	Initiated	Cowen	Outperform
Oct-13-20	Initiated	Evercore ISI	Outperform

View All

Compass Pathways Plc Adr Stock (CMPS) Latest News

Mar 24, 2026

Compass Pathways (NASDAQ: CMPS) posts pivotal TRD wins and targets 2026 NDA - Stock Titan

Mar 24, 2026

Mar 19, 2026

Compass Pathways Eyes Rolling FDA Filing for COMP360, Preps TRD Launch Ahead of Q3 Data - Yahoo Finance

Mar 19, 2026

Mar 17, 2026

Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Short Interest Update - MarketBeat

Mar 17, 2026

Mar 15, 2026

Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 15, 2026

Mar 12, 2026

Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026 - Barchart.com

Mar 12, 2026

Mar 11, 2026

Compass Pathways (NASDAQ:CMPS) Trading Down 6.3%What's Next? - MarketBeat

Mar 11, 2026

Mar 10, 2026

Compass Pathways (NASDAQ:CMPS) Trading 8.8% HigherWhat's Next? - MarketBeat

Mar 10, 2026

Jefferies Financial Group Inc. Invests $7.89 Million in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat

Mar 10, 2026

Mar 09, 2026

CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions - Sahm

Mar 09, 2026

Mar 08, 2026

Compass Pathways Highlights Phase 3 COMP360 TRD Gains, 26-Week Durability and FDA Path at Conference - Yahoo Finance

Mar 08, 2026

Why Did Compass Pathways Stock Rocket Higher Today? - AOL.com

Mar 08, 2026

Mar 07, 2026

Blue Owl Capital Holdings LP Acquires 375,000 Shares of Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat

Mar 07, 2026

Mar 06, 2026

HC Wainwright Has Positive Outlook of CMPS FY2026 Earnings - Defense World

Mar 06, 2026

Mar 05, 2026

HC Wainwright Lifts Earnings Estimates for Compass Pathways - MarketBeat

Mar 05, 2026

Propel Bio Management LLC Makes New $2.92 Million Investment in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat

Mar 05, 2026

ARK Investment Management LLC Buys 471,897 Shares of Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat

Mar 05, 2026

Mar 04, 2026

FY2030 Earnings Forecast for CMPS Issued By HC Wainwright - MarketBeat

Mar 04, 2026

Feb 26, 2026

Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders - Benzinga

Feb 26, 2026

Compass Pathways raises $200M from warrant exercises - Investing.com

Feb 26, 2026

Feb 25, 2026

Compass Pathways (NASDAQ:CMPS) Stock Price Down 6.9%Here's Why - MarketBeat

Feb 25, 2026

Feb 23, 2026

Sonoco Products posts upbeat Q4 earnings, joins Compass Pathways, Masimo, Itron and other big stocks moving higher on Tuesday - MSN

Feb 23, 2026

Feb 20, 2026

Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? - Bitget

Feb 20, 2026

Magic Mushrooms, Hard Cash: Compass Pathways’ Trial Win, Fast Raise - MarketBeat

Feb 20, 2026

Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise - Finviz

Feb 20, 2026

Feb 19, 2026

Cathie Wood’s ARK sells DraftKings stock, buys Figma and Compass Pathways - Investing.com South Africa

Feb 19, 2026

Feb 18, 2026

Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates - Finviz

Feb 18, 2026

Compass Pathways prices $150 million public offering of ADSs By Investing.com - Investing.com South Africa

Feb 18, 2026

Compass Pathways prices $150 million public offering of ADSs - Investing.com

Feb 18, 2026

Compass Pathways announces $150 million ADS offering - Investing.com India

Feb 18, 2026

Rezolve AI PLC (NASDAQ:RZLV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Feb 18, 2026

Mister Car Wash, Inc. (NYSE:MCW) Given Consensus Rating of “Hold” by Analysts - Defense World

Feb 18, 2026

COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Feb 18, 2026

Feb 17, 2026

Compass Pathways announces $150 million ADS offering By Investing.com - Investing.com UK

Feb 17, 2026

COMPASS Pathways touts Phase III psilocybin wins in TRD, eyes FDA NDA and expedited review - Yahoo Finance

Feb 17, 2026

Sonoco Products Posts Upbeat Q4 Earnings, Joins Compass Pathways, Masimo, Itron And Other Big Stocks Moving Higher On Tuesday - Benzinga

Feb 17, 2026

Compass Pathways stock soars after positive Phase 3 trial results By Investing.com - Investing.com India

Feb 17, 2026

Compass Pathways stock soars after positive Phase 3 trial results - Investing.com

Feb 17, 2026

Compass Pathways reports positive phase 3 results for depression drug - Investing.com

Feb 17, 2026

COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Short Interest Update - Defense World

Feb 17, 2026

Feb 16, 2026

Compass Pathways to release new clinical data on psilocybin trials - Investing.com India

Feb 16, 2026

Compass Pathways to release new clinical data on psilocybin trials By Investing.com - Investing.com South Africa

Feb 16, 2026

What is Lifesci Capital’s Estimate for CMPS FY2025 Earnings? - Defense World

Feb 16, 2026

Feb 12, 2026

Compass Pathways Plc receives Investment Bank Analyst Rating Update By Investing.com - Investing.com

Feb 12, 2026

Feb 09, 2026